Default Theme
AIIMS NEW
अखिल भारतीय आयुर्विज्ञान संस्थान, नई दिल्ली
All India Institute Of Medical Sciences, New Delhi
कॉल सेंटर:  011-26589142

Dr. Sudhir Chandra Sarangi

 

 

Brief Biodata: Dr. Sudhir Chandra Sarangi

 

Name: Dr. Sudhir Chandra Sarangi, MBBS, MD, DM (Clinical Pharmacology), MAMS

                    डॉसुधीरचन्द्रसरंगी,
Designation: Additional Professor
               अपर प्रोफेसर 

Affiliation: Department of Pharmacology, All India Institute of Medical Sciences, New Delhi

               भेषजगुण विज्ञान विभाग, अखिल भारतीयआयुर्विज्ञान संस्‍थान, नई दिल्‍ली

Address: Room No-5009, 5th Floor,

                 Department of Pharmacology,

                 Convergence Block,

                 All India Institute of Medical Sciences,

                 New Delhi-110029

Phone: +91 8518881757, 011-26549259

Email Idयह ईमेल पता spambots से संरक्षित किया जा रहा है. आप जावास्क्रिप्ट यह देखने के सक्षम होना चाहिए.

Academic Details:

  • D.M. (Clinical Pharmacology) in the year 2013, All India Institute of Medical Sciences, New Delhi.
  • M.D. (Pharmacology)  in the year 2009, All India Institute of Medical Sciences, New Delhi
  • M.B.B.S (Hons)  in the year 2005, MKCG Medical College, Berhampur

Research Interest/Areas: Clinical Pharmacology, Neuropharmacology, Pharmacovigilance, Drug Safety, Pharmacoeconomics, Pharmacogenomics

Awards/Achievements:

  • Awarded membership by National Academy of Medical Sciences
  • Awarded ‘Bursary’  to attend the 34th International Epilepsy Congress by International League Against Epilepsy (2021)
  • Obtained Certificate of Achievement for poster presentation at 34th, 33rd and 32nd International Epilepsy Congress, 2021, 2019 & 2017.
  • Best Paper Award (2nd prize) in 20th Joint Annual Conference of Indian Epilepsy Society and Indian Epilepsy Association (ECON 2019)
  • Obtained ICMR International Travel support for Non-ICMR scientists for attending 33rd International Epilepsy Congress held at Bangkok, Thailand 22-26 June 2019.
  • Deputy coordinator of Adverse Drug Reaction Monitoring Center at AIIMS under Pharmacovigilance Programme of India

Publications (10 recent and relevant)

  1. Singh R, Sarangi SC, Singh S, Tripathi M. A review on role of metformin as a potential drug for epilepsy treatment and modulation of epileptogenesis. Seizure. 2022 Sep 5;101:253-261. 
  2. Mishra A, Reeta KH, Sarangi SC, Maiti R, Sood M. Effect of add-on alpha lipoic acid on psychopathology in patients with treatment-resistant schizophrenia: a pilot randomized double-blind placebo-controlled trial. Psychopharmacology (Berl). 2022 Sep 7:1–11.
  3. Sarangi SC, Kumar S, Tripathi M, Kaleekal T, Singh S, Gupta YK. Antiepileptic-drug tapering and seizure recurrence: Correlation with serum drug levels and biomarkers in persons with epilepsy. Indian J Pharmacol. 2022 Jan-Feb;54(1):24-32.
  4. Mishra A, Sarangi SC, Maiti R, Sood M, Reeta KH. Efficacy and Safety of Adjunctive Serotonin-Dopamine Activity Modulators in Major Depression: A Meta-Analysis of Randomized Controlled Trials. J Clin Pharmacol. 2022 Jun;62(6):721-732.
  5. Sarangi SC, Medhi B, Prakash A, Prakash J, Gupta YK. Questionnaire-based Pan-India survey for impact assessment of National Formulary of India. Indian J Pharmacol. 2021 Mar-Apr;53(2):115-124.
  6. Sarangi SC, Sopory P, Reeta KH. Chronic Neurological Disorders: Genetic and Epigenetic Markers for Monitoring of Pharmacotherapy. Neurol India. 2021 Mar-Apr;69(2):252-259.
  7. Mishra A, Sarangi SC, Reeta K. First-in-human dose: current status review for better future perspectives. Eur J Clin Pharmacol. 2020 Sep;76(9):1237-1243.
  1. Sarangi SC, Kaur N, Tripathi M. Need for pharmacoeconomic consideration of antiepileptic drugs monotherapy treatment in persons with epilepsy. Saudi Pharm J. 2020;28(10):1228-1237.
  2. Sarangi SC, Pattnaik SS, Joshi D, Chandra PP, Kaleekal T. Adjuvant role of Ocimum sanctum hydroalcoholic extract with carbamazepine and phenytoin in experimental model of acute seizures. Saudi Pharm J. 2020 Nov;28(11):1440-1450.
  3. Kumar S, Sarangi SC, Tripathi M, Ramanujam B, Gupta YK. Seizure recurrence risk in persons with epilepsy undergoing antiepileptic drug tapering. Acta Neurol Scand. 2020 Jan;141(1):65-76.

 

Author of books/book chapters: Eight chapters

  1. Author of one chapter in ‘IAN Textbook of Neurology’ by Dr A. A. Mukherjee and Dr G. Singh. Edition 2018.
  2. Author of one chapter in ‘Nanogels in Biomedical Applications’ by A Vasisth, AK Kaushik, S Ahmad, M Nair, Royal Society of Chemistry, UK, Edition 2018.
  3. Author of six chapters in the book‐ 'Advanced Pharmacology' by B. Medhi& A. Prakash, Edition 2014.

             

             

Zo2 Framework Settings

Select one of sample color schemes

Google Font

Menu Font
Body Font
Heading Font

Body

Background Color
Text Color
Link Color
Background Image

Header Wrapper

Background Color
Modules Title
Text Color
Link Color
Background Image

Menu Wrapper

Background Color
Modules Title
Text Color
Link Color
Background Image

Main Wrapper

Background Color
Modules Title
Text Color
Link Color
Background Image

Inset Wrapper

Background Color
Modules Title
Text Color
Link Color
Background Image

Bottom Wrapper

Background Color
Modules Title
Text Color
Link Color
Background Image
Background Color
Modules Title
Text Color
Link Color
Background Image
 
Top of Page
BCMath lib not installed. RSA encryption unavailable